Zai Lab Limited ("Zai Lab" or the "Company") , an innovative, commercial-stage biopharmaceutical company, today announced the pricing of its underwritten public offering of 7,843,137 American ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback